We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+10.11%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$47.1B
AUM Growth
+$2.61B
(+5.9%)
Cap. Flow
-$501M
Cap. Flow
% of AUM
-1.06%
Top 10 Holdings %
Top 10 Hldgs %
14.43%
Holding
3,576
New
705
Increased
706
Reduced
825
Closed
988
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$417M |
| 2 |
Meta Platforms (Facebook)
META
|
+$383M |
| 3 |
Amazon
AMZN
|
+$308M |
| 4 |
Microsoft
MSFT
|
+$293M |
| 5 |
GE Aerospace
GE
|
+$263M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$312M |
| 2 |
Bank of America
BAC
|
+$292M |
| 3 |
ExxonMobil
XOM
|
+$274M |
| 4 |
lululemon athletica
LULU
|
+$238M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.05% |
| 2 | Technology | 14.35% |
| 3 | Consumer Discretionary | 13.97% |
| 4 | Financials | 9.9% |
| 5 | Industrials | 6.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Clarus
CLAR
$126M
| $5.82M | 0.01% |
616,067
-129,016
| -17% | -$1.21M |
|
902
Applied Materials
AMAT
$410B
| $5.81M | 0.01% |
47,322
-79,278
| -63% | -$9.1M |
|
903
W.P. Carey
WPC
$17B
| $5.81M | 0.01% |
76,612
+48,137
| +169% | +$3.84M |
|
|
MNTV
904
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $5.8M | 0.01% |
+622,675
| New | +$4.89M |
|
|
PR
905
Permian Resources
PR
$17B
| $5.79M | 0.01% |
551,829
-1,302,607
| -70% | -$13.3M |
|
906
CME Group
CME
$91.8B
| $5.79M | 0.01% |
+30,240
| New | +$5.47M |
|
907
Weis Markets
WMK
$1.85B
| $5.79M | 0.01% |
68,391
-3,742
| -5% | -$313K |
|
908
CRH
CRH
$68.7B
| $5.79M | 0.01% |
+113,725
| New | +$5.39M |
|
|
CWAN
909
DELISTED
Clearwater Analytics
CWAN
| $5.78M | 0.01% |
+361,860
| New | +$6.33M |
|
910
Pultegroup
PHM
$24.9B
| $5.77M | 0.01% |
99,026
+70,026
| +241% | +$3.78M |
|
911
Insulet
PODD
$11.4B
| $5.75M | 0.01% |
18,033
-113,362
| -86% | -$33.6M |
|
|
PDCO
912
DELISTED
Patterson Companies, Inc.
PDCO
| $5.74M | 0.01% |
+214,572
| New | +$6.03M |
|
913
Zscaler
ZS
$23.8B
| $5.72M | 0.01% |
48,964
-376,319
| -88% | -$45.1M |
|
914
Cullen/Frost Bankers
CFR
$10.3B
| $5.71M | 0.01% |
54,162
+51,753
| +2,148% | +$6.44M |
|
915
Analog Devices
ADI
$181B
| $5.68M | 0.01% |
28,820
-195,384
| -87% | -$35M |
|
916
Sigma Lithium
SGML
$1.12B
| $5.68M | 0.01% |
+151,077
| New | +$4.84M |
|
|
IXAQW
917
CALL
DELISTED
IX Acquisition Corp. Warrant
IXAQW
| $5.67M | 0.01% |
550,542
| – | – |
|
|
LSI
918
DELISTED
Life Storage, Inc.
LSI
| $5.64M | 0.01% |
43,042
-8,050
| -16% | -$931K |
|
919
Full Truck Alliance
YMM
$9.66B
| $5.64M | 0.01% |
741,104
+613,046
| +479% | +$4.86M |
|
920
Sprinklr
CXM
$1.42B
| $5.64M | 0.01% |
+435,147
| New | +$4.41M |
|
921
California Resources
CRC
$4.51B
| $5.61M | 0.01% |
145,606
+125,606
| +628% | +$5.2M |
|
|
DNMR
922
DELISTED
Danimer Scientific, Inc.
DNMR
| $5.59M | 0.01% |
40,517
+923
| +2% | +$84.4K |
|
923
iShares TIPS Bond ETF
TIP
$14.5B
| $5.59M | 0.01% |
50,700
-263,388
| -84% | -$28.5M |
|
924
Fair Isaac
FICO
$29.7B
| $5.58M | 0.01% |
+7,937
| New | +$5.28M |
|
925
PUT
FedEx
FDX
$73.5B
| $5.55M | 0.01% |
24,300
+300
| +1% | +$60.9K |
|
Similar funds
Marshall Wace's Q1 2023 Portfolio in Review
As of Q1 2023, Marshall Wace held 3,576 positions worth $47.1B, up 5.9% from $44.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Marshall Wace's Q1 2023 filing shows 705 new, 706 increased, 825 reduced and 988 closed positions. Its largest new stake was Madrigal Pharmaceuticals: 541,764 shares worth $131M. The largest sale was Cigna, an estimated $312M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
- Marshall Wace's largest Q1 2023 buy was Madrigal Pharmaceuticals: 541,764 shares worth $131M.
- Marshall Wace added most to Walmart Inc in Q1 2023, an estimated $417M increase.
- Marshall Wace's biggest Q1 2023 reduction was Cigna, cutting an estimated $312M.
- Marshall Wace fully exited Merck in Q1 2023, selling an estimated $115M.
- Marshall Wace's ten largest holdings make up 14% of its $47.1B portfolio in Q1 2023.
- Marshall Wace opened 705 new positions and closed 988 in Q1 2023.
- Marshall Wace's portfolio value rose 5.9% quarter-over-quarter to $47.1B.
Based on Marshall Wace's 13F filing for Q1 2023, filed 15 May 2023.